Georgia has become the second state to shield pesticide manufacturers from some lawsuits claiming that they failed to warn ...

Bayer Q1 profit declined to $1.45 billion, but earnings and sales topped estimates as pharma growth offset crop science ...

Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...

Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ETCompany ParticipantsBill Anderson - Chairman & CEOWolfgang Nickl ...

Thanks to hefty sales increases from kidney disease drug Kerendia and prostate cancer treatment Nubeqa, Bayer’s pharma ...

Bayer said on Tuesday that the U.S. Supreme Court could decide as early as next month whether it will hear the German company ...

Meanwhile, Bayer CEO Bill Anderson said Donald Trump’s Most Favored Nations policy could present an opportunity for European ...

Bayer shares jumped after the company reported better-than-expected sales and adjusted earnings for the first quarter, with ...

German pharmaceutical and agrochemical company Bayer saw profits fall in the first quarter of 2025, primarily due to lower ...

Bayer’s strong first quarter performance was mainly driven by its pharmaceuticals division, even as its crop-science branch ...

FRANKFURT (Reuters) -Bayer on Tuesday posted a slower decline in first-quarter adjusted earnings than the market had feared ...

Results from studies at Virginia Commonwealth University (VCU) show that an Aramchol and Bayer's Regorafenib drug combination significantly reduced hepatic tumor ...